Dr. Kirk Nylen, a neuropharmacology expert and Managing Director at Baszucki Group, shares groundbreaking insights on the ketogenic diet's potential for improving pediatric mental health, particularly in children with bipolar disorder. He discusses two ongoing studies: CABIN, a multi-site trial assessing ketogenic therapy, and a real-world pilot study by CMHRC. The conversation emphasizes the urgent need for innovative solutions as youth mental health issues rise, highlighting how ketogenic interventions could enhance treatment options for clinicians.
